Basic demographics | N=40 |
Sex ratio (male/female) | 11:29 |
Age at onset (years, mean±SD) | 31.7±14.1 |
Age at examination (years, mean±SD) | 36.5±14.6 |
Follow-up period (months, mean±SD)* | 93.0±91.8 |
Disease duration (months, mean±SD)* | 137.9±124.8 |
Mode of onset | n/N (%) |
Acute | 6/31 (19.4) |
Subacute | 14/31 (45.2) |
Chronic | 11/31 (35.5) |
Clinical course | n/N (%) |
Monophasic | 10/38 (26.3) |
Relapse–remitting | 20/38 (52.6) |
Chronic progressive | 8/38 (21.1) |
Initial symptoms | n/N (%) |
Related to CNS involvement | 15/38 (39.5) |
Related to PNS involvement | 15/38 (39.5) |
Simultaneous or sequential | 8/38 (21.0) |
Fulfilment of MS or CIDP criteria | n/N (%) |
McDonald criteria for MS | 27/40 (67.5) |
EFNS/PNS definite criteria for CIDP | 35/40 (87.5) |
Symptoms and signs during the entire course | n/N (%) |
Seizure† | 3/40 (7.5) |
Mental disturbance† | 5/40 (12.5) |
Visual disturbance† | 19/40 (47.5) |
Right | 1/19 (5.3) |
Left | 8/19 (42.1) |
Bilateral | 10/19 (52.6) |
Cranial nerve involvement (other than the optic nerves) | 17/39 (43.6) |
Motor weakness‡ | 37/40 (92.5) |
Hemiplegia† | 10/36 (27.8) |
Paraplegia† | 6/36 (16.7) |
Weakness of 4 extremities§ | 24/36 (66.7) |
Muscle atrophy§ | 11/40 (27.5) |
Respiratory disturbance | 3/40 (7.5) |
Gait disturbance | 31/39 (79.5) |
Cerebellar ataxia† | 10/38 (26.3) |
Sensory disturbance | 37/39 (94.9) |
Half-body involvement† | 5/37 (13.5) |
Sensory level† | 14/37 (37.8) |
Glove and stocking type§ | 22/37 (59.4) |
Other types | 3/37 (8.1) |
Deep tendon reflexes | |
Hyporeflexia§ | 26/40 (65.0) |
Normal | 1/40 (2.5) |
Hyper-reflexia† | 9/40 (22.5) |
Both hyporeflexia and hyper-reflexia | 4/40 (10.0) |
Pathological reflexes† | 18/40 (45.0) |
Sphincter disturbance† | 18/38 (47.4) |
*Two patients’ data were missing.
†Symptoms derived from CNS involvement.
‡Detail of motor weakness in one patient was unknown.
§Symptoms derived from PNS involvement.
CCPD, combined central and peripheral demyelination; CIDP, chronic inflammatory demyelinating polyradiculoneuropathy; CNS, central nervous system; n, number of involved cases; N, number of cases collated; MS, multiple sclerosis; PNS, peripheral nervous system.